Impilo and Anders Larnholt form a partnership to create a new pan-European pharmaceutical platform
STOCKHOLM, Dec. 15, 2020 /PRNewswire/
The Nordic investment company Impilo has partnered with Anders Larnholt, a pharma and healthcare executive and entrepreneur, to create a new platform; Mallax Pharmaceuticals AB ( Mallax ). Mallax was founded in Sweden, with the aim of building a company with established pharmaceuticals and OTC products for customers and patients across Europe. I m very pleased to enter into a partnership with Impilo. They have a profound understanding of the healthcare sector and are long term investors. Sustainability, medical need, and profitable growth are cornerstones of Mallax s strategy, and they will define how we operate and build our company , says Anders Larnholt, Founder and CEO of Mallax.